RVPH Stock Analysis: Buy, Sell, or Hold?
RVPH - Reviva Pharmaceuticals Holdings, Inc. Common Stock
$0.29
-0.01 (-2.11%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Mar 23, 2026
Get Alerted When RVPH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
3 traders called RVPH this week
67% bullish • 1 bearish
67% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: RVPH is down 10.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: RVPH is down 10.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: RVPH is currently trading at $0.29, which is considered slightly low relative to its 30-day fair value range of $0.27 to $0.39.
Technical Outlook: Technically, RVPH is in a strong downtrend. Immediate support is located at $0.28, while resistance sits at $0.37.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $4.81 (+1511.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, RVPH is in a strong downtrend. Immediate support is located at $0.28, while resistance sits at $0.37.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $4.81 (+1511.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$0.27 -
$0.39
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
Protect Your Profits
Holding RVPH? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1511.1% below Wall St target ($4.81)
- WARNING: Recommendation downgraded due to -10.3% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$0.27 -
$0.39
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.28
Resistance Level
$0.37
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-1.11
Wall Street Target
$4.81
(+1511.1%)
Last updated: January 31, 2026 12:09 AM ET
Data refreshes hourly during market hours. Next update: 1:09 AM
Data refreshes hourly during market hours. Next update: 1:09 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RVPH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 54 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$486 | 45 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$214 | 60 BUY |
|
ACAD
ACADIA Pharmaceuticals I… |
BUY
20 analysts |
$31 | 55 HOLD |
|
ORIC
Oric Pharmaceuticals Inc |
STRONG BUY
12 analysts |
$21 | 58 HOLD |
Advanced RVPH Option Strategies
Professional options setups generated by AI based on today's RVPH price and gamma walls.
